Immature myeloid cells and cancer-associated immune suppression.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 6, p. 293, doi. 10.1007/s00262-002-0280-8
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2002 AND VI 51 AND IP 6
Results: 7
1
2
Immunogenicity of WT-1 peptides.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 6, p. 349, doi. 10.1007/s00262-002-0303-5
- By:
- Publication type:
- Article
3
Effect of the dose and composition of an autologous hapten-modified melanoma vaccine on the development of delayed-type hypersensitivity responses.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 6, p. 320, doi. 10.1007/s00262-002-0285-3
- By:
- Publication type:
- Article
4
Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell–leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 6, p. 299, doi. 10.1007/s00262-002-0284-4
- By:
- Publication type:
- Article
5
Linkage of CD40L to a self-tumor antigen enhances the antitumor immune responses of dendritic cell-based treatment.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 6, p. 341, doi. 10.1007/s00262-002-0283-5
- By:
- Publication type:
- Article
6
Molecular requirements for CD8-mediated rejection of a MUC1-expressing pancreatic carcinoma: implications for tumor vaccines.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 6, p. 327, doi. 10.1007/s00262-002-0277-3
- By:
- Publication type:
- Article
7
Hsp110 over-expression increases the immunogenicity of the murine CT26 colon tumor.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 6, p. 311, doi. 10.1007/s00262-002-0287-1
- By:
- Publication type:
- Article